Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test Waltham, MA, May 09, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has continued to make significant progress in expanding contracts to provide laboratory services and ExoDx®...

Exosome Diagnostics and Chesapeake Urology Partner to Evaluate Clinical Value of ExoDx® Prostate(IntelliScore) in First Study Under Novel Evidence Development Collaboration Baltimore, MD and Boston, MA, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics (ExoDx) and Chesapeake Urology announced today that they have initiated a new evidence development study to...